AboutKarl Karlsson, PhD

As a lead on the Sg2 Consulting team, Karl leverages nearly 20 years of experience in life sciences to develop strategies for health care systems and life sciences companies.

On a day-to-day basis, Karl is either actively involved in advising health systems on future-focused strategies to capture smart growth, or working with pharma, medical technology and diagnostic firms to better understand trends impacting health care providers and align strategies to meet the needs of their customers. He has particular expertise in enterprise, service line and ambulatory strategy development, as well as specific interest in market and health system segmentation and strategy development to support innovative partnerships between health care providers and suppliers.

Karl earned a PhD from the University of Oxford in the United Kingdom, where he developed cell culture models to study HIV drug targets. He received a BSc in biochemistry and pharmacology from King’s College London.

Karl is married with two sons and lives in Chicago, IL. He enjoys teaching his sons Swedish, being an amateur photographer and expressing his scientific curiosity through cooking.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube